English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113160/144130 (79%)
Visitors : 50736465      Online Users : 367
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    政大機構典藏 > 理學院 > 心理學系 > 期刊論文 >  Item 140.119/120073
    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/120073


    Title: Review article: the prevention of hepatitis B‐related hepatocellular carcinoma
    Authors: 林志陵
    Lin, C.-L.
    Kao, J.‐H.
    Contributors: 心理系
    Date: 2018-07
    Issue Date: 2018-09-12 14:00:26 (UTC+8)
    Abstract: Background : Ample evidence indicates an aetiological association of persistent hepatitis B virus (HBV) infection with hepatocellular carcinoma (HCC). Several viral, host and external risk factors for the development of HBV‐related HCC have been documented. Aims : To summarise and discuss the risk stratification and the preventive strategies of HBV‐related HCC. Methods : Recent published studies identified from PubMed were comprehensively reviewed. The key words included chronic hepatitis B, HBV, hepatocellular carcinoma, prevention and antiviral therapy.
    Results : The incidence of HCC is extremely high in HBV hyperendemic areas. For HBV patients left untreated, significant risk factors for HCC include male gender, aging, advanced hepatic fibrosis, persistent serum transaminase elevation, specific HBV entry receptor (NTCP) genotype, PM2.5 exposure, HBeAg positivity, HBV genotype C/D/F, high proportion of core promoter mutation, pre‐S deletion, high serum levels of HBV DNA and HBsAg as well as co‐infection with HCV, HDV and HIV. Primary prevention of HBV‐related HCC can be achieved through universal HBV vaccination and anti‐viral prophylaxis for high viraemic mothers. The goal of secondary prevention has been reached by effective anti‐viral therapy to reduce the risk of HCC development in chronic hepatitis B patients. However, whether HCC is prevented or delayed deserves further examination. Finally, several studies confirmed the tertiary preventive effect of anti‐viral therapy in reducing risk of HCC recurrence after curative therapies. Conclusions : Through the strategies of three‐level prevention, the global burden of HBV‐related HCC should decline over time and even be eliminated in conjunction with HBV cure.
    Relation: Volume48, Issue1 , Pages 5-14
    Data Type: article
    DOI 連結: https://doi.org/10.1111/apt.14683
    DOI: 10.1111/apt.14683
    Appears in Collections:[心理學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    14683.pdf481KbAdobe PDF2541View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback